Back
EyePoint Pharmaceuticals Vs. Adverum Biotechnologies Industry Stock Comparison
Sell
40
EYPT
EyePoint Pharmaceuticals
Last Price:
8.21
Seasonality Move:
-9.25%
Sell
32
ADVM
Adverum Biotechnologies
Last Price:
6.82
Seasonality Move:
-1.86%
Sell
40
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $8.01. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Adverum Biotechnologies (ADVM)
is a Sell
Is Adverum Biotechnologies a Buy, Sell or Hold?
- The current Adverum Biotechnologies [ADVM] share price is $6.59. The Score for ADVM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ADVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $8.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADVM Stock Price Chart
What is Adverum Biotechnologies's stock price today?
-
The Adverum Biotechnologies share price today is $6.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing selling pressure, which indicates risk of future bearish movement.
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 42.06 | Sell |
Chaikin Money Flow: | 232993 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.06 - 8.9) | Sell |
Bollinger Bands (100): | (8.03 - 10.53) | Sell |
ADVM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 42.65 | Sell |
Chaikin Money Flow: | -165680 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.74 - 7.22) | Sell |
Bollinger Bands (100): | (6.72 - 8.12) | Sell |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.22 | Sell |
20-day SMA: | 8.42 | Sell |
50-day SMA: | 8.66 | Sell |
200-day SMA: | 15.98 | Sell |
8-day EMA: | 8.2 | Sell |
20-day EMA: | 8.4 | Sell |
50-day EMA: | 8.83 | Sell |
200-day EMA: | 12.03 | Sell |
ADVM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.88 | Sell |
20-day SMA: | 6.99 | Sell |
50-day SMA: | 7.07 | Sell |
200-day SMA: | 10.35 | Sell |
8-day EMA: | 6.86 | Sell |
20-day EMA: | 6.96 | Sell |
50-day EMA: | 7.19 | Sell |
200-day EMA: | 9.37 | Sell |
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.
Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.62 per share, and an increase next year of $0.42 per share.
EyePoint Pharmaceuticals Technical Analysis
Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adverum Biotechnologies Technical Analysis
Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |